Head and Neck Tumors Unit
What does the Unit treat?
The Head and Neck Tumors Unit is a national reference unit, specialized in the treatment of squamous cell carcinomas of the ENT (ear, nose, and throat) area, which are a type of cancer that originates in the squamous cells lining the surfaces of the head and neck, such as the mouth, throat, larynx, and nose.
At HM Hospitals (CIOCC), the Head and Neck Tumors Unit focuses on:
- Development of clinical trials for patients with localized and metastatic squamous cell carcinomas of the ENT area.
- Next-generation immunotherapies, mainly immune checkpoint inhibitors, which help the immune system recognize and attack cancer cells.
Related Diseases
- Salivary gland tumors.
- Laryngeal cancer.
- Thyroid cancer.
- Craniopharyngioma.
- Oral cancer.
Who is this Unit for?
The Head and Neck Tumors Unit is aimed at:
- Patients with localized and metastatic squamous cell carcinomas of the ENT area.
- Patients seeking to participate in clinical trials with next-generation immunotherapies.
- Family members and caregivers seeking information and support for their loved ones with head and neck tumors.
- Healthcare professionals who wish to refer patients for specialized head and neck tumor evaluation and treatment.
How do we approach it at HM Hospitals?
Surgery
We aim to remove as much of the tumor as possible, preserving the function of the reproductive organs to the maximum extent.
Chemotherapy
We use state-of-the-art medications to reach and destroy cancer cells that may be present anywhere in the body.
Radiotherapy
We direct high-energy beams to destroy cancer cells, minimizing damage to surrounding healthy tissues.
Targeted therapies
They act on specific molecular targets of cancer cells, selectively disrupting their growth and spread.
Immunotherapy
Through drugs, we stimulate the patient’s immune system to naturally recognize and attack cancer cells.